OPTUM FRONTIER THERAPIES II, LLC SOS Verified
6425 SANTA MARGARITA ST UNIT 110, LAS VEGAS, NV 89118
NPI Number
1720364532
Practice location · View on Google Maps
SOS Verification: Verified
Entity Name: Optum Frontier Therapies II, LLC
Entity Number: E0308272011-9
Entity Type: Domestic Limited-Liability Company
Entity Status: Active
Formation Date: 2011-05-31
Name Match: 95%
Registered Agent
Name: UNITED AGENT GROUP INC.
Type: Commercial Registered Agent
Address: 112 NORTH CURRY STREET, Carson City, NV, 89703
Officers / Principals
| Title | Name | Address | Status |
|---|---|---|---|
| Manager | Erin Satterwhite | 1 Optum Circle, Eden Prairie, MN | Active |
| Manager | Kathryn Carey | 1 Optum Circle, Eden Prairie, MN | Active |
Total Medicaid Payments
$9,339,450
+9400% vs specialty average
Patients Seen
5,512
Total Claims
6,779
$ Per Patient
$1,694
Specialty avg: $329
Specialty Rank
#1 of 95
Pharmacy, Community/Retail Pharmacy providers in Nevada
Peer Average
$98,312
Average total for Pharmacy, Community/Retail Pharmacy
Claims per Patient
1.2
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $4,458,858 | |
| 2019 | $3,463,359 | |
| 2020 | $1,417,233 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | 4,232 | $3,880,321 | 41.5% | $917 |
| J2357 | Injection, omalizumab, 5 mg | 1,477 | $3,276,741 | 35.1% | $2,219 |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | 651 | $1,685,320 | 18.0% | $2,589 |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 239 | $199,174 | 2.1% | $833 |
| J2315 | Injection, naltrexone, depot form, 1 mg | 119 | $150,965 | 1.6% | $1,269 |
| J2182 | Injection, mepolizumab, 1 mg | 61 | $146,928 | 1.6% | $2,409 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.